Are Insurance Companies Ready for the AI Build-vs-Buy Question? in UK

Direct answer: Most UK insurance companies are not ready for the AI build-vs-buy question because they have been treating AI tooling as a line-item purchase rather than a long-term infrastructure decision. The pressure to decide is rising fast: vendor pricing on AI tools is climbing as usage scales, and lock-in into a single provider's roadmap is becoming a real operational risk. The companies that get ahead of this treat it as an architecture decision now, before renewal cycles force a rushed one later.

Through August 2026, UK tech sector commentary has been converging on a specific pattern among UK SMEs: as AI tools move from pilot projects to embedded parts of daily operations, the economics of buying versus building are shifting under their feet. Vendor pricing for AI-powered SaaS tools tends to scale with usage, seats, or API calls in ways that were easy to underestimate during a free trial or an early discounted tier. At the same time, businesses that adopted a vendor's AI features quickly are discovering how difficult it is to move workflows, data, and trained processes to a different platform once that vendor becomes the operational backbone. This is not a hypothetical concern raised by consultants looking for work — it is showing up in how UK SMEs across sectors are now approaching contract renewals and new AI purchases, insurance included. For an industry that already runs on long-lived systems, decades-old policy administration platforms, and data that cannot simply be exported and re-imported without risk, this build-vs-buy tension lands harder than it does for a retail or hospitality business swapping out a scheduling tool.

What's Actually Happening With AI Vendor Pricing and Lock-In

The pattern UK tech sector commentary is describing has three parts, and it's worth separating them because each creates a different kind of risk.

Pricing that scales faster than value

Early AI tool pricing in the UK SME market was often structured to drive adoption — flat monthly fees, generous usage caps, "starter" tiers priced to make procurement easy. As adoption matures, many vendors are moving toward consumption-based pricing tied to API calls, document volumes, or active users. For a business that adopted an AI tool when it processed a few hundred queries a month and now processes tens of thousands, the bill can grow far faster than the value delivered per query did. This isn't unique to any one vendor category — it shows up in customer service AI, document processing tools, and analytics platforms alike.

Lock-in through data and workflow, not just contract terms

The more insidious form of lock-in isn't a long contract term — it's the fact that a vendor's AI tool becomes the place where your workflows, your prompt templates, your fine-tuned behaviors, and often your historical data live. Switching costs compound quietly. A tool that seemed like a plug-in add-on a year ago can become the thing an entire claims-triage or customer-response process depends on, and unwinding that dependency later is expensive in ways that weren't visible at signup.

The build option looking more viable than it used to

What's changed the calculation is that building custom AI-powered tooling is no longer the multi-year, seven-figure undertaking it was a few years ago. Modern frameworks for retrieval, agent orchestration, and LLM integration have matured enough that a well-scoped custom build is a realistic option for a mid-market business — not just an enterprise with an in-house engineering team. That's precisely why UK SMEs are having this conversation now: the buy side is getting more expensive and less flexible at the same time the build side is getting more accessible.

Why this is surfacing now, specifically

The timing isn't random. Most UK SMEs that adopted AI tooling did so between 2023 and 2025, during an initial wave of vendor competition where pricing was aggressive and feature sets were still narrow. Two or three years into those relationships, contracts are hitting renewal, usage has grown past initial estimates, and the tools have become embedded enough in daily operations that switching now carries real friction. That combination — a maturing contract cycle plus deeper operational dependency — is what's pushing the build-vs-buy question from a background consideration into an active decision point across 2026. Insurance companies, with their longer planning cycles, are typically a step behind general SME sentiment on any given technology trend, which means many are only now confronting a version of this question that other sectors started working through a year or two earlier.

Why This Matters More for Insurance Companies Than Most Sectors

Insurance is not a sector where you can experiment loosely with vendor tooling and shrug off a bad fit six months later. A handful of structural realities make the build-vs-buy question sharper here.

Data sensitivity and regulatory exposure. Policy data, claims history, and underwriting inputs are exactly the kind of sensitive information that regulators scrutinize closely. Handing that data into a third-party AI vendor's infrastructure, especially one whose pricing or ownership structure might change, adds a layer of exposure that a general-purpose SME doesn't carry to the same degree. Every AI vendor relationship in insurance is implicitly a data-processing relationship, and that changes what "just try the tool" actually costs in risk terms.

Legacy system entanglement. Most UK insurers, from smaller regional providers to larger composite insurers, run core administration and claims systems that were never designed with AI integration in mind. A bought AI tool typically expects to sit on top of clean APIs and modern data structures. When it doesn't get that, insurers either pay a systems integrator to bridge the gap (adding to the vendor's sticker price) or they compromise on what the tool can actually do. A custom build, by contrast, can be designed from day one to work with the legacy stack as it actually exists.

Long product and claims cycles. Insurance products can run for years, and claims can take months to resolve. A vendor tool priced attractively today, on a roadmap you don't control, might not exist in its current form by the time a multi-year policy matures or a complex claim resolves. Betting core claims-triage logic or underwriting-assist tooling on a vendor's continued existence and pricing stability is a longer-duration bet in insurance than in almost any other SME context.

Competitive differentiation risk. If every insurer in a given line is buying the same off-the-shelf AI underwriting assistant from the same handful of vendors, none of them are differentiating on it — they're all paying for the same commodity capability, and any actual edge in risk assessment or customer experience has to come from elsewhere, likely custom-built. The vendors profiting from this dynamic have no particular incentive to help buyers reach that conclusion.

The talent gap cuts both ways. Many mid-sized UK insurers don't have a large in-house team of AI or machine learning engineers, which is exactly why buying a ready-made vendor tool looked appealing in the first place — it promised capability without the hiring problem. But that same talent gap makes a custom build feel intimidating, which is often what keeps insurers defaulting to "buy" even after the economics have shifted. The resolution isn't necessarily hiring an internal AI team; it's partnering with an external development team that already has the expertise, which removes the talent gap as a reason to avoid the build option by default.

None of this means every insurer needs to build everything from scratch. It means the decision deserves the same rigor insurers already apply to reinsurance treaties or reserving models — because in practice, AI tooling that touches underwriting, claims, or customer data is now core infrastructure, not a peripheral efficiency tool.

What Changes in Practice for an Insurer's Systems and Roadmap

If build-vs-buy becomes a deliberate decision rather than a default toward "buy because it's faster," several practical things shift in how an insurance company plans its technology roadmap.

Procurement needs an exit clause, not just a price

Before signing or renewing any AI vendor contract, the practical question isn't just "what does this cost per month" — it's "what does it cost to leave, and how much of our operational logic lives inside this vendor's black box." Data portability terms, API access guarantees, and the ability to export historical interactions in a usable format should be non-negotiable line items in procurement, not afterthoughts raised only when a renewal goes badly.

AI vendor review belongs in the same governance process as other core risk decisions

Most insurers already have a formal process for reviewing reinsurance treaties, reserving assumptions, or core system vendors — a committee, a periodic review cycle, sign-off from risk and compliance, not just IT. AI vendor contracts that touch underwriting, claims, or customer data increasingly deserve the same level of governance, rather than being approved through a lighter-weight procurement path because they were originally adopted as a productivity tool. Folding AI vendor decisions into existing governance also creates a natural checkpoint for the build-vs-buy question to get asked at the right moments, instead of only surfacing informally when someone on the team notices the bill has grown.

Architecture decisions get made earlier, not after the fact

Teams that wait until a vendor relationship becomes painful to think about alternatives usually find that the integration work has already made switching expensive. The more resilient pattern is architecting AI-touching workflows — claims intake, document extraction, customer query handling — with an abstraction layer from the start, so the underlying AI provider can be swapped without rebuilding the whole workflow. This is a systems design conversation as much as a vendor conversation, and it belongs in the same planning process as any other core software investment. Our piece on AI Agent Architecture: How Autonomous Workflows Actually Work goes into how that kind of modular, swappable structure is actually built underneath an AI-driven workflow, which is worth understanding before locking into any single vendor's way of doing things.

Some workloads make more sense to own outright

Not every AI use case is worth building in-house — a general-purpose transcription tool or a commodity chatbot widget rarely justifies a custom build. But workloads that touch proprietary risk models, sit close to regulated data, or represent a genuine point of competitive differentiation are increasingly candidates for custom development rather than a subscription. This is where Custom Software Development becomes the more defensible long-term choice: an insurer that owns the code, the data pipeline, and the deployment environment isn't exposed to a vendor's next pricing change or a sudden feature deprecation.

Customer-facing experience still needs craft, not just capability

As insurers build or extend AI-touching interfaces — claims portals, quote tools, chat-based support — the interface layer matters as much as the underlying model. A capable AI backend wrapped in a clunky or over-animated front end erodes the trust it's supposed to build with policyholders navigating what can already be a stressful process (a claim, a renewal, a coverage question). Our guide on Motion Design in UI: When Animation Helps and When It Hurts is directly relevant here — insurance interfaces benefit from restraint, using motion to clarify status (a claim moving through review, a document being processed) rather than to decorate.

Discoverability changes too

As more insurance customers research coverage and claims questions through AI assistants rather than traditional search, how an insurer's own content and product information gets surfaced by those systems becomes a factor worth planning for alongside the build-vs-buy decision itself. Our piece on Answer Engine Optimization: Getting Cited by ChatGPT and Perplexity covers how that visibility actually works, which matters whether the underlying AI tooling is bought or built.

How Should an Insurance Company Actually Decide?

There's no universal formula, but a workable framework starts with three questions applied to each AI-touching workflow under consideration.

Is this workload close to our core risk model or customer data? If yes, lean toward build or at minimum toward a vendor solution with strong data portability and no proprietary lock-in on the model logic itself. If the workload is genuinely commodity — general document OCR, basic scheduling — buying remains the sensible default.

What does switching cost look like in two years, not two months? Model out the total cost of a vendor relationship including realistic usage growth, not the pricing tier you'd sign up for today. Compare that honestly against the cost of a scoped custom build plus its ongoing maintenance, rather than comparing a subscription's monthly fee against a build's total upfront cost — that's not an apples-to-apples comparison.

Do we have, or can we get, the technical partner to build and maintain it? A custom build only pays off if it's engineered properly and maintained over time. This is where working with an experienced software development partner rather than assembling an ad hoc internal effort makes the difference between an asset and a liability.

A precise figure for how much UK insurers are currently spending on AI vendor tooling, or how that compares to build costs sector-wide, is not publicly available at this level of specificity — the trend commentary describes a directional pattern across UK SMEs rather than insurance-specific benchmarking. Reasoning from the general pattern, though, the direction is clear enough to act on: usage-based AI pricing tends to compound, and lock-in costs are almost always underestimated at signup.

It also helps to run this framework on a rolling basis rather than as a one-time exercise. A workflow that scores as "buy" today — low data sensitivity, commodity capability, cheap to switch — can shift categories within a year if the vendor changes its pricing model, if the workflow starts touching more sensitive data as it expands, or if the tool becomes more deeply wired into adjacent systems than originally planned. Building a short annual review into the technology roadmap, alongside existing budget and vendor reviews, keeps the decision current instead of letting it calcify around whatever choice was made when the workflow was first adopted. This is a small process change, but it's the difference between catching a lock-in risk while it's still cheap to address and discovering it at the worst possible moment — mid-renewal, with no real alternative lined up.

What This Kind of Work Typically Costs

Custom software development for AI-touching insurance workflows varies with scope, but Scult's service tiers give a useful reference point for where this kind of project typically lands.

Tier	Starting Price	Typical Fit
Essential	$1,000	A single scoped workflow — for example, a document-intake tool with a swappable AI layer
Growth	$2,000	A multi-workflow build — claims triage, customer query handling, and portal integration together
Enterprise	$4,000+	Full custom platforms integrating legacy administration systems, proprietary risk logic, and multiple AI-touching workflows with long-term support

These figures reflect starting points for scoped engagements, not a ceiling — the right tier depends on how many workflows are in play and how deep the legacy integration work runs.

Key Takeaways

• Vendor pricing on AI tools is increasingly usage-based, and costs can scale well past what an early pilot or discounted tier suggested — model this out before renewing.
• Lock-in in AI tooling is mostly about data and workflow dependency, not contract length — evaluate portability and exit costs at signup, not at renewal.
• Insurance-specific factors — regulated data, legacy core systems, long claims cycles — make the build-vs-buy decision higher-stakes than it is for most UK SMEs.
• Workloads close to proprietary risk models or regulated customer data are the strongest candidates for custom development rather than a subscription.
• Architecting AI-touching workflows with a swappable provider layer from the start avoids the expensive rebuild that comes from deciding to switch too late.
• Customer-facing AI interfaces need the same design discipline as the backend decision — capability without craft undermines policyholder trust.

Getting the build-vs-buy call right takes an honest look at your specific workflows, your legacy systems, and your actual usage growth, not a generic industry answer. If you want help working through that for your organization, book a meeting with our team.

Frequently Asked Questions

What does "build vs buy" mean in the context of AI tooling for insurance companies?

It refers to the decision between subscribing to a third-party AI vendor's software versus commissioning a custom-built AI-powered tool designed specifically around your workflows and data. For insurance companies, this decision usually centers on claims processing, underwriting assistance, or customer-facing tools rather than generic productivity software.

Why is vendor pricing on AI tools increasing?

Many vendors that launched with flat or discounted pricing to drive adoption are shifting to usage-based models tied to API calls, document volumes, or active seats as their customer base matures. As AI tooling gets embedded deeper into daily operations, usage naturally climbs, and so does the bill, often faster than the value delivered scales.

What exactly is "AI vendor lock-in"?

It's the difficulty of moving away from a vendor once your workflows, historical data, and trained processes depend on that vendor's specific platform. It's rarely about contract terms alone — the deeper cost is rebuilding integrated workflows and migrating data in a usable format.

Why does this affect insurance companies more than other UK SMEs?

Insurance companies handle regulated, sensitive data, run on legacy core systems that weren't built for modern AI integration, and operate on long product and claims cycles. Each of these factors raises the cost and risk of a bad vendor decision compared to a typical SME software purchase.

Is this trend specific to the UK, or global?

The commentary grounding this pattern comes from UK tech sector sources describing UK SME behavior specifically, though the underlying dynamics of usage-based AI pricing and lock-in are not unique to the UK. The regulatory and procurement context discussed here is UK-focused.

Should a smaller UK insurer just avoid AI tools altogether to sidestep this risk?

No — avoiding AI tooling entirely just cedes efficiency and customer-experience gains to competitors who use it well. The point is to make the build-vs-buy decision deliberately, workflow by workflow, rather than defaulting to whichever option seemed easiest at the time of purchase.

What kinds of insurance workflows are best suited to custom builds?

Workflows that touch proprietary risk models, regulated customer data, or represent real competitive differentiation — such as claims triage logic tuned to your specific book of business, or underwriting-assist tools built around your actual risk criteria — tend to justify custom development more than commodity tasks like general transcription.

What kinds of workflows are fine to buy off the shelf?

Generic, low-risk capabilities that don't touch proprietary logic or sensitive data directly — basic scheduling assistants, general-purpose document OCR, or standard chatbot widgets for non-sensitive queries — are usually not worth building custom.

How do I estimate the true cost of a vendor AI tool over time?

Model usage growth realistically over at least two years, not just the current month's bill, and include the cost of any integration work needed to connect the tool to your existing systems. Compare that total against a custom build's upfront cost plus its ongoing maintenance, rather than comparing a subscription's monthly fee to a build's one-time cost.

What should be in an AI vendor contract to reduce lock-in risk?

Data portability guarantees, the ability to export historical interactions and configurations in a usable format, and clear API access terms should all be negotiated before signing, not requested only when a relationship turns sour.

How long does a custom AI-touching workflow build typically take?

Timelines vary by scope, but a single scoped workflow — like a document-intake tool with a swappable AI layer — can often be delivered in a matter of weeks, while a full platform integrating multiple legacy systems and workflows takes considerably longer. Scope definition upfront is what most affects the timeline.

Does building custom mean we lose access to the latest AI model improvements?

Not if the system is architected with an abstraction layer between your workflow logic and the underlying AI provider. That structure lets you swap in improved models or even different providers without rebuilding the whole workflow, which is actually a more resilient position than being tied to one vendor's roadmap.

What is an "abstraction layer" in this context, in plain terms?

It's a design pattern where your core workflow logic talks to a standardized internal interface, and that interface connects to whichever AI provider or model you're using underneath. If you need to switch providers, you update the connection behind the interface rather than rewriting the workflow itself.

Is a custom AI build more expensive than a SaaS subscription?

Not necessarily over a multi-year horizon once usage-based vendor pricing and integration costs are factored in. The comparison depends heavily on your specific usage growth and how much custom integration a bought tool would need to work with your existing systems.

What regulatory considerations apply to AI tooling handling UK insurance data?

Any AI tool processing policy data, claims history, or underwriting inputs is effectively a data-processing relationship and should be evaluated with the same data governance rigor as any other regulated data handler, including where and how data is stored and processed. This is a question to raise directly with legal and compliance teams alongside the technical evaluation.

Can a mid-sized UK insurer realistically build custom AI tooling without a large in-house engineering team?

Yes — this is precisely what has changed in the last few years. Modern frameworks for AI integration have matured to the point where a well-scoped custom build is achievable by partnering with an experienced software development team, without requiring the insurer to staff a large internal engineering function.

What happens if we don't decide and just let vendor contracts auto-renew?

Auto-renewal without review tends to lock in whatever pricing and terms the vendor has moved to, including usage-based increases, without the leverage of a genuine negotiation or comparison against alternatives. It also delays the architecture decisions that make switching easier later, compounding the eventual cost of change.

How does legacy core system integration affect this decision?

If your policy administration or claims system is older and lacks modern APIs, a bought AI tool may require expensive middleware or a systems integrator to connect properly, effectively adding hidden cost to the "buy" option. A custom build can be designed around your legacy stack from the outset, which sometimes makes it cheaper in practice despite a higher sticker price upfront.

What's the risk of every insurer buying the same off-the-shelf AI tool?

If most insurers in a line of business use the same vendor's AI underwriting or claims tool, none of them gain differentiation from it — everyone pays for the same commodity capability. Genuine competitive advantage in risk assessment or customer experience increasingly has to come from proprietary, custom-built capability instead.

Should claims processing be a priority area for this decision?

Claims processing is often a strong candidate for scrutiny because it touches sensitive customer data, runs on potentially long cycles, and is an area where efficiency gains directly affect customer satisfaction and cost ratios. It's a reasonable starting point for applying the build-vs-buy framework described here.

How do we know if our current AI vendor is becoming a lock-in risk?

Warning signs include difficulty exporting your configuration or historical data, pricing that has shifted from flat to usage-based since you signed, and workflows that would require significant rework to move to another provider. If several of these apply, it's worth assessing switching costs now rather than waiting for a forced renewal decision.

Is now a bad time to sign a new AI vendor contract given these trends?

Not necessarily — the point isn't to avoid vendor contracts, but to negotiate them with data portability and pricing predictability in mind, and to reserve genuinely proprietary or sensitive workflows for custom development. A well-negotiated vendor contract for the right workload is still often the faster and cheaper option.

What role does customer-facing design play in an insurer's AI strategy?

The interface layer affects whether policyholders trust and successfully use AI-touching tools like claims portals or quote assistants, regardless of how capable the underlying model is. Poor interface design, including overuse of animation or unclear status feedback, can undermine an otherwise well-built backend.

How does Answer Engine Optimization relate to an insurer's build-vs-buy decision?

As more customers use AI assistants to research coverage and claims questions, how your own content and product information gets surfaced by those systems becomes a discoverability factor worth planning for alongside your internal AI tooling decisions. It's a related but separate concern from which AI tools you buy or build internally.

What's the first practical step for an insurer that hasn't thought about this yet?

Start by inventorying every AI-touching workflow currently in use or under consideration, and for each one, ask whether it's close to core risk or regulated data. That inventory becomes the basis for deciding which workflows deserve deeper build-vs-buy analysis first.

Does this apply to brokers and intermediaries too, or only insurers underwriting risk directly?

The same dynamics apply to brokers and intermediaries handling sensitive client data and using AI tools for quoting or customer communication, even though they may not carry underwriting risk directly. The data sensitivity and lock-in concerns are largely the same.

How do we compare a vendor's roadmap risk against a custom build's maintenance burden?

A vendor's roadmap risk is largely outside your control — pricing changes, feature deprecations, or even the vendor being acquired can all affect you without warning. A custom build's maintenance burden is more predictable and within your control, provided you've engaged a development partner capable of supporting it long-term.

What's a realistic first project size for testing this approach?

An Essential-tier scoped project — a single well-defined workflow like document intake with a swappable AI layer — is a reasonable way to test the custom-build approach without committing to a full platform rebuild upfront.

How do we avoid ending up locked into our own custom build instead of a vendor's?

Apply the same abstraction-layer discipline to your custom build that you'd want from a vendor: keep the AI provider interface swappable, document the architecture, and avoid hardcoding assumptions about a single model or provider throughout your workflow logic.

Can existing AI tools be kept while we transition specific workflows to custom builds?

Yes — this is usually the most practical path. Most insurers migrate workload by workload rather than replacing every AI tool at once, keeping low-risk commodity tools on subscription while moving higher-risk or higher-value workflows to custom development over time.

What's the biggest mistake insurers make in this decision?

The most common mistake is treating an AI tool purchase as a simple software line item rather than an infrastructure decision, which means data portability, pricing scalability, and integration depth never get evaluated until a problem forces the issue. Deciding is delayed until a bad renewal or a scaling cost makes it not a choice at all.

How does data ownership factor into the decision?

With a custom build, your business retains ownership of the code, the data pipeline, and typically the deployment environment, whereas a vendor relationship generally leaves your operational data inside their infrastructure under their terms. For regulated data in insurance, ownership clarity is often worth more than it initially appears.

Are there hybrid approaches between fully buying and fully building?

Yes — many insurers use vendor tools for commodity capabilities while building custom orchestration or integration layers around them, giving some of the flexibility of a custom build without replacing every underlying AI capability. This is often a practical middle ground for teams not ready for a full custom platform.

What's the risk of moving too slowly on this decision?

Moving slowly usually means absorbing vendor pricing increases as they happen and accumulating deeper workflow dependency on a vendor's platform, both of which raise the eventual cost of any future switch. The cost of inaction compounds quietly rather than announcing itself.

How do smaller insurers compete with larger insurers who have bigger AI budgets?

Custom development lowers the barrier that used to favor only large insurers with dedicated engineering teams, letting smaller insurers build proprietary, differentiated tooling through an experienced development partner rather than needing a large internal team. Scope and focus matter more than budget size for a well-executed custom build.

What ongoing costs come with a custom AI-touching system after launch?

Ongoing costs typically include hosting, monitoring, occasional model or API updates, and maintenance as your workflows evolve, similar in kind to maintaining any custom software system. These costs are generally more predictable than an escalating usage-based vendor subscription.

How do we evaluate whether a vendor's AI tool actually delivers proportional value for its rising cost?

Track the specific business metric the tool is meant to improve — claims processing time, quote turnaround, query resolution rate — against the tool's actual cost over time, not just against its initial price. If the cost curve is outpacing the value curve, that's a signal to revisit the build-vs-buy question for that workflow.

Does GDPR affect how UK insurers should approach AI vendor selection?

Any AI vendor processing personal or sensitive customer data needs data-processing terms consistent with UK data protection obligations, and this should be reviewed with legal counsel as part of vendor evaluation, not treated as a technical afterthought. It's a relevant consideration whether you choose to build or buy, since custom builds carry their own data handling responsibilities too.

What is "usage-based pricing" and why does it matter here?

It's a pricing model where cost scales with how much you actually use a tool — API calls, documents processed, active seats — rather than a flat fee. It matters because usage tends to grow as a tool becomes embedded in operations, meaning costs can rise well beyond what was budgeted at signup.

How specific should the build-vs-buy analysis be — per tool, or per workflow?

Per workflow is more useful than per tool, since a single vendor tool might touch multiple workflows with very different risk and value profiles. Evaluating at the workflow level lets you make different build-or-buy calls even for capabilities from the same vendor.

What's the relationship between this trend and the broader UK SME AI adoption pattern?

UK SMEs broadly are moving from experimental AI pilots to embedded operational use, and the pricing and lock-in dynamics described here are a direct consequence of that maturation across sectors, not something unique to insurance. Insurance simply experiences sharper consequences due to its data sensitivity and legacy systems.

Can Scult help assess whether a specific workflow should be built or bought?

Yes — that kind of workflow-by-workflow assessment, weighing data sensitivity, legacy integration needs, and cost trajectory, is exactly the kind of scoping conversation to have before committing to either path. Book a meeting to walk through your specific systems and workflows.

How do agent-based AI architectures relate to this decision?

Understanding how autonomous AI agent workflows are actually structured helps clarify what you'd be either buying from a vendor or building yourself, since many modern AI tools for claims or underwriting assistance are built on agent-style architectures under the hood. That structural understanding makes it easier to evaluate vendor claims and scope a custom alternative accurately.

What's a reasonable timeline for revisiting this decision if we choose to buy for now?

Revisit the decision at each contract renewal point, and sooner if usage or pricing shifts meaningfully outside what was projected at signup. Treating it as a one-time decision rather than a recurring check is how insurers end up locked in without realizing it happened.

Does this affect life insurers differently than general/property insurers?

The core dynamics — data sensitivity, legacy systems, long product cycles — apply across both, though life insurers often have even longer product durations, which can make vendor roadmap risk an even more significant factor in the decision. The framework applies similarly regardless of the specific line of business.

What questions should we ask an AI vendor before signing, specific to lock-in?

Ask directly what data and configuration you can export, in what format, and how quickly; whether pricing tiers have changed historically and by how much; and what happens to your workflows if you choose to leave. Vague or evasive answers to these questions are themselves useful signals.

How do we build internal buy-in for a custom build over a familiar SaaS subscription?

Frame the comparison around total cost and control over a multi-year horizon rather than sticker price alone, and use a small scoped pilot project to demonstrate feasibility before committing to a larger build. Concrete results from a contained first project tend to build internal confidence more effectively than an abstract proposal.

Is there a risk in delaying this decision until AI regulation in the UK is clearer?

Waiting for full regulatory clarity means continuing to absorb current vendor pricing and lock-in dynamics in the meantime, and regulation is unlikely to resolve the underlying economics of usage-based pricing regardless. It's more practical to build flexibility into your architecture now than to wait for external certainty that may not fully arrive.

What's the honest downside of building custom AI tooling instead of buying?

A custom build requires a genuine, ongoing relationship with a capable development partner and more upfront scoping discipline than clicking through a vendor's signup flow. It's not the right choice for every workflow, which is why a workflow-by-workflow evaluation matters more than a blanket policy either way.

Who inside an insurance company should own this decision?

It typically needs joint ownership between IT or technology leadership and risk or compliance functions, rather than sitting solely with procurement or a single department that happens to use the tool day to day. Because the decision touches data governance, long-term cost, and operational dependency, treating it as a cross-functional review rather than a single-team purchase tends to produce better outcomes.